Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Publication | Open Access

DOI Full Paper Access

426

Citations

References

2009

Year

Richard Sylvester, Maurizio Brausi, Wim J. Kirkels, Wolfgang Hoeltl, Fernando Calais da Silva, Philip Powell, Stephen M. Prescott, C. van de Beek, Thierry Gorlia, Theo M. de Reijke

European Urology

Urological ResearchUrologyBacillus Calmette-guérinUrologic Cancer EpidemiologyGenitourinary CancerMedicineStudy 30911UrogynecologyLong-term Efficacy ResultsOncologyRadiation OncologyCancer Research